Table 3.

Secondary outcomes and other drugs consumption

Variables	Overall n=79	SAPB group n=43	ESPB group n=35	P
Rass 3h	-4.00 (-5.00 to -4,00)	-5.00 (-5.00 to -3,00)	-4,00 (-4,00 to -4,00)	0.25
Rass 6h	0.00 (-3.00 to 0.00)	-2.00 (-3.50 to 0,00)	0.00 (-0.00 to 0.00)	0.002*
Rass 12 h	0.00 (0.00 to 0.00)	0.00 (0.00 to 0.00)	0.00 (0.00 to 0.00)	0.31
Nausea 24 h	3 (3.80%)	3 (100%)	0 (0%)	0.24
Nausea 48 h	2 (2.53%)	2 (100%)	0 (0%)	0.49
Bowel activity 24 h	23 (29.11%)	11 (47.80%)	12 (52.20%)	0.46
Bowel activity 48 h	32 (40.50%)	15 (46.90%)	17 (53.10%)	0.36
Mv duration (min)	425.00 (330.00-600.00)	495.00 (330.00-700.00)	420.00 (330.00-520.00)	0.12
Vfds (days)	27.00 (26.00-27.00)	26.00 (26.00-27.00)	27.00 (26.00-27.00)	0.14
Icu discharge (days)	1.00 (1.00-1.00)	1.00 (1.00-1.00)	1.00 (1.00-1.00)	0.54
Hospital discharge (days)	6.00 (5.00-7.00)	6.00 (5.00-8.00)	6.50 (6.00-7.00)	0.85
Ketorolac (mg)	0.00 (0.00-30.00)	0.00 (0.00-30.00)	0.00 (0.00-0.00)	0.002*
Metoclopramide (mg)	0.00 (0.00-0.00)	0.00 (0.00-0.00)	0.00 (0.00-0.00)	0.048*
Ondasetron (mg)	0.00 (0.00-1.00)	0.00 (0.00-0.00)	0.00 (0.00-4.00)	0.14

MV duration: Mechanical ventilation duration, time (min) between ICU admission and extubation; VFDS: ventilator free days, one point [for] each day during the measurement period that [patients] are both alive and free of mechanical ventilation in the first 28 days; ICU discharge: time (days) between ICU admission and discharge; Hospital discharge: time (days) between ICU discharge and hospital discharge; RASS: Richmond Agitation Sedation Scale; SAPB: serratus anterior plane block; ESPB: erector spinae plane block; Note: Results are presented as median (range 25-75), mean with 95% confidence interval and percentages, *, significant result